Frontier IP Matthew White joining the Group as Director of Commercialisation

Neil Crabb, Chief Executive of Frontier IP, said: “It is a real pleasure to welcome Matthew to the Frontier IP team. His superb range of skills and experience provide an excellent match for the work many of our portfolio companies are undertaking.”

Frontier IP (LON:FIPP), which specialises in commercialising university intellectual property, today announced that Matthew White, the Head of Innovation at AB Sugar, one of the world’s largest sugar producers and a wholly-owned subsidiary of AB Foods, is joining the Group as Director of Commercialisation, in a non-board role.

Matthew has 23 years’ experience in technology, product and service innovation, business development and marketing. As AB Sugar’s Head of Innovation, he was responsible for defining strategy and managing a global innovation portfolio. The role involved working extensively with university partners on collaborative research programmes totalling over £20million.

Before joining AB Sugar, Matthew was Director of Consumer Products for international technology consulting and product development business Sagentia Limited, working across a wide range of sectors.

He started his career at Neotronics Scientific, one of the first companies to commercialise electronic odour sensing. He has a Natural Sciences degree majoring in Chemistry from the University of Cambridge.

Matthew White, said: “It is fantastic to be joining everyone at Frontier IP. I am looking forward to using my network and experience to accelerate the commercialisation activities of our exciting portfolio.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Frontier IP Group Plc

    More articles like this

    Frontier IP Group Plc

    AI Drug Development Hit The News

    Following a recent story with the top twenty companies in the area of AI drug development, this time we will make a flight over this new ecosystem looking for the bright lights of a rigorous developing

    Frontier IP Group Plc

    Life sciences sector in Dundee earns parliamentary praise

    MSPs debated the importance of life sciences to the Scottish economy on Wednesday to mark the second anniversary of the industry-led Life Sciences Strategy. North East Scotland Conservative MSP Bill Bowman praised efforts to strengthen partnerships

    Frontier IP Group Plc

    Frontier IP named in Five AIM share tips for 2019

    Former AIM writer of the year Andrew Hore names the AIM companies he believes have strong growth prospects over the next year and beyond. Frontier IP (FIPP) Frontier IP (LON:FIPP) develops businesses and technologies that are

    Frontier IP Group Plc

    An Insight Of AI’s Penetration In Drug Development Market

    A recent article about AI-based drug development, indicates the progressive use of A.I. technologies for the drug production industry, mining the huge amount of data collected from the pharmaceutical companies’ data centres. Thanks to Deep Knowledge

    Frontier IP Group Plc

    How artificial intelligence is changing drug discovery

    An enormous figure looms over scientists searching for new drugs: the estimated US$2.6-billion price tag of developing a treatment. A lot of that effectively goes down the drain, because it includes money spent on the nine

    Frontier IP Group Plc

    Pharma companies put faith in AI for breakthroughs

    In 2013, US start-up Berg was asked by the Department of Defence to help improve the detection of prostate cancer, a disease which is common among pilots. Less than five years later, an artificial intelligence-driven tool

    Frontier IP Group Plc

    Frontier IP Exscientia acquires Kinetic Discovery

    Frontier IP Chief Executive Officer Neil Crabb said: “We are delighted with this news from Exscientia. The acquisition adds to the exciting potential of what the Company can achieve in the field of AI-driven drug discovery.”

    Frontier IP Group Plc

    Frontier IP Group Plc portfolio companies increased by 34%

    Neil Crabb, CEO of Frontier IP Group plc, commented: “Frontier IP is going from strength to strength. There is strong evidence that our distinctive approach to intellectual property commercialisation, designed to address the needs of both

    Frontier IP Group Plc

    10 outstanding start-ups from Oxford to watch

    Oxford is a hotbed of AI, deep tech, space and medtech talent, capitalising on the university city’s prowess and heritage in research and science. Home to the oldest university in the English-speaking world, the University of

    Frontier IP Group Plc

    AI in Healthcare: 5 Real-World Examples

    The examples of AI and its applications in healthcare potentially offer affordable healthcare, efficient clinical trials, improved success rates and a better quality of life. While many of us may be familiar with AI in the

    Frontier IP Group Plc

    Frontier IP Group Second Portuguese spin out Des Solutio

    Frontier IP chief executive Neil Crabb said: “We’re very excited about the possibilities for Des Solutio. The technology being developed by Professor Ana Rita Duarte and Dr Alexandre Paiva has already attracted interest from major multinationals.